Tuesday, 25 January, 2022
TopicFixed-dose combination drugs

Topic: fixed-dose combination drugs

Drug price regulator NPPA worried about drug cocktails, flags ‘over-medication, profiteering’

The NPPA observations came this week as it took up applications to fix the prices of 34 new drugs, most of which were fixed-dose combination medicines or drug cocktails.

3 banned drug cocktails get all-clear from Modi govt but could have few takers in pharma sector

The three drugs were banned in the first round of the govt’s FDC crackdown in 2007, and hundreds of others have been outlawed since.

Govt approves manufacture of 471 cocktail drugs related to vitamins, minerals, micronutrients

The safety of these fixed drug combinations will be monitored regularly and any failure on the manufacturers' part to submit a periodic safety update will be deemed illegal.

Modi govt likely to ban 80 more ‘irrational’ drug cocktails by next month

The medicines that could be banned are antibiotics Orflaz, Nuforce 3 kit and Vaginobact, and hypertension drugs Telipril H and Ramtel H.

On Camera


Why Federal Reserve will no longer have pandemic-era investors’ backs

Inflation is top of mind for all leaders in Washington and US President Joe Biden, whose approval ratings are sliding, appears less inclined to count on hope as a strategy.

SEBI seeks tighter environmental, social & governance rules to address risk of greenwashing

In a consultation paper released Monday, SEBI said increasing reliance on unregulated ESG rating providers poses risks to investor protection, transparency & efficiency of markets.


File photo of Scorpene-class submarine 'INS Vela', at the Naval Dockyard in Mumbai | ANI

Kamov choppers, submarine torpedoes among deals defence ministry will review this week

Ministry is reviewing all procurement under the ‘Buy (Global)’ category, under which equipment is bought directly from foreign manufacturers, amid govt's 'Atmanirbhar' push.

Modi vs non-BJP CMs: When most popular isn’t all-powerful & why Centre-state ties will worsen

Modi’s inability to win many states, and the huge popularity his rivals enjoy there, is pushing Indian politics in a more robustly federal direction.